Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children.
- DOI
- 10.1007/s40119-026-00456-6
- Published
- 2026 Sep
- Container
- Cardiology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40119-026-00456-6,
title = {Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children.},
author = {Lava SAG and Laurence C and Mallory J and Della Pasqua O and Di Deo A and Villa C and Lang S and Quail M and Burch M},
year = {2026},
journal = {Cardiology and therapy},
doi = {10.1007/s40119-026-00456-6},
url = {https://doi.org/10.1007/s40119-026-00456-6}
}RIS
TY - JOUR TI - Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children. AU - Lava SAG AU - Laurence C AU - Mallory J AU - Della Pasqua O AU - Di Deo A AU - Villa C AU - Lang S AU - Quail M AU - Burch M PY - 2026 JO - Cardiology and therapy DO - 10.1007/s40119-026-00456-6 UR - https://doi.org/10.1007/s40119-026-00456-6 ER -
APA
SAG, L., C, L., J, M., O, D. P., A, D. D., C, V., S, L., M, Q., & M, B. (2026). Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children.. Cardiology and therapy. https://doi.org/10.1007/s40119-026-00456-6
Source records
- pubmed · retrieved 2026-09-26T18:49:39.940Z